Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
暂无分享,去创建一个
Jacques P. Brown | H. Genant | A. Grauer | T. Keaveny | K. Engelke | J. Finkelstein | P. Lakatos | S. Goemaere | B. Langdahl | C. Libanati | D. Kendler | M. Bolognese | J. Malouf | L. Hyldstrup | N. Daizadeh | M. Ulla | E. Dokoupilová | D. Crittenden | E. Jódar-Gimeno | J. Molina | J. Maddox | F. Massari